Michael Brines

ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes

Albert Dahan, Monique van Velzen, A. Dahan, 2015, Molecular medicine.

Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy

Albert Dahan, Daniel A Culver, Monique van Velzen, 2018, Scientific Reports.

ARA 290 for treatment of small fiber neuropathy in sarcoidosis

Albert Dahan, Monique van Velzen, Marieke Niesters, 2014, Expert opinion on investigational drugs.

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

Pietro Ghezzi, Laura Calvillo, P. Ghezzi, 2003, Proceedings of the National Academy of Sciences of the United States of America.